PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
-6.88%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$216M
AUM Growth
-$123M
(-36%)
Cap. Flow
-$76.5M
Cap. Flow
% of AUM
-35.45%
Top 10 Holdings %
Top 10 Hldgs %
42.5%
Holding
85
New
16
Increased
22
Reduced
28
Closed
18
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.77M |
| 2 |
Schrodinger
SDGR
|
$3.45M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$3.37M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$3.2M |
| 5 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$2.58M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$14.2M |
| 2 |
Boston Scientific
BSX
|
$12.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.82M |
| 4 |
Tandem Diabetes Care
TNDM
|
$8.05M |
| 5 |
Teleflex
TFX
|
$7M |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Technology | 1.17% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
51
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $1.14M | 0.53% |
6,236
-1,533
| -20% | -$280K |
|
52
VYNE Therapeutics
VYNE
$7.62M
| $1.09M | 0.5% |
+5,644
| New | +$1.09M |
|
53
Aprea Therapeutics
APRE
$9.03M
| $1.04M | 0.48% |
+1,502
| New | +$1.04M |
|
54
Gyre Therapeutics
GYRE
$698M
| $941K | 0.44% |
+28,698
| New | +$941K |
|
55
MannKind Corp
MNKD
$1.7B
| $928K | 0.43% |
901,117
-524,185
| -37% | -$540K |
|
56
Halozyme
HALO
$8.76B
| $908K | 0.42% |
50,466
-114,534
| -69% | -$2.06M |
|
|
GNMK
57
DELISTED
GenMark Diagnostics, Inc
GNMK
| $824K | 0.38% |
200,000
-220,000
| -52% | -$906K |
|
58
Mustang Bio
MBIO
$10.4M
| $813K | 0.38% |
405
+2
| +0.5% | +$4.02K |
|
|
RCM
59
DELISTED
R1 RCM Inc. Common Stock
RCM
| $786K | 0.36% |
86,492
-119,228
| -58% | -$1.08M |
|
|
RETA
60
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $726K | 0.34% |
5,027
-10,973
| -69% | -$1.58M |
|
61
Astria Therapeutics
ATXS
$424M
| $645K | 0.3% |
+25,912
| New | +$645K |
|
62
Immunovant
IMVT
$2.99B
| $625K | 0.29% |
+40,125
| New | +$625K |
|
63
Standard BioTools
LAB
$497M
| $572K | 0.27% |
225,391
-174,609
| -44% | -$443K |
|
|
AMRN
64
Amarin Corp
AMRN
$317M
| $304K | 0.14% |
3,806
-2,978
| -44% | -$238K |
|
65
Apyx Medical
APYX
$74.1M
| $127K | 0.06% |
35,497
+102
| +0.3% | +$365 |
|
66
ClearPoint Neuro
CLPT
$314M
| $90K | 0.04% |
+25,078
| New | +$90K |
|
67
Ascendis Pharma
ASND
$12.5B
| – | – |
-23,004
| Closed | -$3.2M |
|
68
BioLife Solutions
BLFS
$1.27B
| – | – |
-166,000
| Closed | -$2.69M |
|
|
69
Boston Scientific
BSX
$159B
| – | – |
-275,000
| Closed | -$12.4M |
|
|
FTSV
70
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| – | – |
-40,000
| Closed | -$1.58M |
|
|
FOMX
71
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – |
-932,141
| Closed | -$3.1M |
|
|
BHVN
72
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-20,000
| Closed | -$1.09M |
|
73
Guardant Health
GH
$7.5B
| – | – |
-30,250
| Closed | -$2.36M |
|
74
OrthoPediatrics
KIDS
$524M
| – | – |
-60,000
| Closed | -$2.82M |
|
75
Regenxbio
RGNX
$490M
| – | – |
-85,000
| Closed | -$3.48M |
|